Swedbank
MED icon

Swedbank’s Medifast MED Stock Holding History

Swedbank’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,000
Closed -$115K – 712
2024
Q1 		$115K Hold
3,000
– – ﹤0.01% 699
2023
Q4 		$202K Hold
3,000
– – ﹤0.01% 691
2023
Q3 		$225K Hold
3,000
– – ﹤0.01% 684
2023
Q2 		$276K Hold
3,000
– – ﹤0.01% 683
2023
Q1 		$311K Hold
3,000
– – ﹤0.01% 686
2022
Q4 		$346K Sell
3,000
-3,100
-51% -$361K ﹤0.01% 681
2022
Q3 		$661K Hold
6,100
– – ﹤0.01% 669
2022
Q2 		$1.1M Hold
6,100
– – ﹤0.01% 636
2022
Q1 		$1.04M Hold
6,100
– – ﹤0.01% 675
2021
Q4 		$1.29M Hold
6,100
– – ﹤0.01% 674
2021
Q3 		$1.18M Buy
+6,100
New +$1.5M ﹤0.01% 680

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Swedbank's MED Position: Q2 2024 in Review

Swedbank sold out of Medifast (MED) in Q2 2024, closing a stake of 3,000 shares — an estimated $115K sold.

Swedbank first reported a position in MED in Q3 2021 and held it in 11 quarters. The position peaked at $1.29M in Q4 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Swedbank reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Swedbank sold 3,000 Medifast shares in Q2 2024, an estimated $115K.
  • Swedbank first reported a position in Medifast in Q3 2021 and held it in 11 quarters.
  • Swedbank's Medifast position peaked at $1.29M in Q4 2021.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Swedbank's 13F filing for Q2 2024, filed 11 Jul 2024.